INBS - צמיחת הכנסות ב-12 חודשים נגררים Intelligent Bio Solutions

The rolling 12-month YoY revenue growth chart for Intelligent Bio Solutions (INBS) on GURU.Markets illustrates revenue dynamics, where the 36.70 metric determines the parameter status. Intelligent Bio Solutions (INBS) brings together medical professionals and engineers to develop non-contact drug testing. Its staff of bioengineers creates portable devices based on unique patents. Currently, the R&D division is implementing a biosensor platform for fingerprint analysis via diagnostic cartridges.

The long-term reliability of the issuer is determined by the business's ability to scale operating income. This indicator measures the daily revenue growth rate over a rolling year, neutralizing seasonality. By analyzing the year-over-year dynamics of core revenue over a rolling 12-month period, an investor assesses the actual stability of cash flows. Local dips here may signal a correction in demand. For Intelligent Bio Solutions (INBS), this growth confirms the commercial demand for its patented non-invasive testing systems.